Loyal raised $22M in Series B-2 funding led by Valor Equity Partners to expand operations and enhance R&D efforts.
Loyal raised $22M in Series B-2 funding led by Valor Equity Partners to expand operations and enhance R&D efforts.
02/27/25, 1:42 AM
Location
atlantaMoney raised
$22 million
Investors
Collaborative Fund, Valor Equity Partners
Loyal, a clinical-stage animal health company based in San Francisco, raised $22M in its Series B-2 funding round. The funding, led by Valor Equity Partners and Collaborative Fund, aims to support the company's expansion and development of innovative drugs for dogs.
Company Info
Location
atlanta, georgia, united states
Additional Info
One of the first companies to offer end-to-end digital and AI-powered solutions spanning the entirety of the patient journey, Loyal is the preferred software solution for improved care utilization among the nation's leading health systems and hospitals. From selecting a provider best suited for them to closing the feedback loop on their experience, patients who engage with healthcare networks via our proprietary platform quite simply, tend to be more loyal. Learn how to streamline patients' navigation of your health system and network of clinical services at LoyalHealth.com.